{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:38:05Z","timestamp":1793104685443,"version":"4.5.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ophtha.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T01:48:24Z","timestamp":1508377704000},"page":"S34-S47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"special_numbering":"S","title":["Neuropathic Corneal Pain"],"prefix":"10.1016","volume":"124","author":[{"given":"Gabriela","family":"Dieckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2439-4780","authenticated-orcid":false,"given":"Sunali","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Hamrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ophtha.2017.08.004_bib1","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.pain.2013.06.004","article-title":"Interventional management of neuropathic pain: NeuPSIG recommendations","volume":"154","author":"Dworkin","year":"2013","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.ophtha.2017.08.004_bib2","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A\u00a0new definition of neuropathic pain","volume":"152","author":"Jensen","year":"2011","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jtos.2012.01.002","article-title":"The corneal pain system. Part I: the missing piece of the dry eye puzzle","volume":"10","author":"Rosenthal","year":"2012","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bjophthalmol-2014-306280","article-title":"Ocular neuropathic pain","volume":"100","author":"Rosenthal","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"13","key":"10.1016\/j.ophtha.2017.08.004_bib5","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1167\/iovs.16-20557","article-title":"Oculofacial pain: corneal nerve damage leading to pain beyond the eye","volume":"57","author":"Rosenthal","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jtos.2015.01.005","article-title":"Autologous serum tears for treatment of photoallodynia in patients with corneal neuropathy: efficacy and evaluation with in\u00a0vivo confocal microscopy","volume":"13","author":"Aggarwal","year":"2015","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jtos.2016.10.002","article-title":"Corneal nerve and epithelial cell alterations in corneal allodynia: an in\u00a0vivo confocal microscopy case series","volume":"15","author":"Hamrah","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtos.2016.09.004","article-title":"In\u00a0vivo confocal microscopy of corneal nerves in health and disease","volume":"15","author":"Cruzat","year":"2017","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.ophtha.2017.08.004_bib9","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/OPX.0000000000000652","article-title":"Corneal neuralgia after LASIK","volume":"92","author":"Theophanous","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib10","first-page":"310","article-title":"Neuropathic ocular pain due to dry eye is associated with multiple comorbid chronic pain syndromes","volume":"17","author":"Galor","year":"2016","journal-title":"J\u00a0Pain"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2014.263","article-title":"Neuropathic ocular pain: an important yet underevaluated feature of dry eye","volume":"29","author":"Galor","year":"2015","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/17469899.2015.1061431","article-title":"Understanding the true burden of dry eye disease","volume":"10","author":"Galor","year":"2015","journal-title":"Expert Rev Ophthalmol"},{"issue":"1-2","key":"10.1016\/j.ophtha.2017.08.004_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08820538.2015.1114853","article-title":"Understanding neuropathic corneal pain\u2013gaps and current therapeutic approaches","volume":"31","author":"Goyal","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.08.004_bib14","author":"Oxford Centre for Evidence-Based Medicine"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1016-8478(23)25242-5","article-title":"Painful channels in sensory neurons","volume":"20","author":"Lee","year":"2005","journal-title":"Mol Cells"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib16","first-page":"19","article-title":"From nociception to pain perception: imaging the spinal and supraspinal pathways","volume":"207","author":"Brooks","year":"2005","journal-title":"J\u00a0Anat"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40135-015-0073-9","article-title":"What causes eye pain?","volume":"3","author":"Belmonte","year":"2015","journal-title":"Curr Ophthalmol Rep"},{"issue":"16","key":"10.1016\/j.ophtha.2017.08.004_bib18","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1523\/JNEUROSCI.20-16-06289.2000","article-title":"Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin","volume":"20","author":"Opree","year":"2000","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/jpet.106.105569","article-title":"Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity","volume":"319","author":"Lin","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"20","key":"10.1016\/j.ophtha.2017.08.004_bib20","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1523\/JNEUROSCI.0300-04.2004","article-title":"Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury","volume":"24","author":"Hains","year":"2004","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1542-0124(12)70224-0","article-title":"Post-LASIK tear dysfunction and dysesthesia","volume":"8","author":"Nettune","year":"2010","journal-title":"Ocul Surf"},{"issue":"2 Suppl","key":"10.1016\/j.ophtha.2017.08.004_bib22","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ophtha.2007.10.012","article-title":"Herpes zoster antivirals and pain management","volume":"115","author":"Pavan-Langston","year":"2008","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bjophthalmol-2015-308214","article-title":"Patients with more severe symptoms of neuropathic ocular pain report more frequent and severe chronic overlapping pain conditions and psychiatric disease","volume":"101","author":"Crane","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ajo.2011.02.026","article-title":"Prevalence and risk factors of dry eye syndrome in a United States Veterans Affairs population","volume":"152","author":"Galor","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajo.2012.02.009","article-title":"Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database","volume":"154","author":"Galor","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1167\/iovs.09-4180","article-title":"McMonnies questionnaire: enhancing screening for dry eye syndromes with Rasch analysis","volume":"51","author":"Gothwal","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ophtha.2017.08.004_bib28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/ICO.0b013e318294b0c0","article-title":"Psychometric properties and validation of the Standard Patient Evaluation of Eye Dryness questionnaire","volume":"32","author":"Ngo","year":"2013","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ophtha.2017.08.004_bib29","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","article-title":"Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2017.08.004_bib30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00003226-200208000-00009","article-title":"Performance and repeatability of the NEI-VFQ-25 in patients with dry eye","volume":"21","author":"Nichols","year":"2002","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ophtha.2017.08.004_bib31","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ophtha.2015.02.037","article-title":"Comparison of two questionnaires for dry eye symptom assessment: The Ocular Surface Disease Index and the symptom assessment in dry eye","volume":"122","author":"Amparo","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.ophtha.2017.08.004_bib33","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ophtha.2016.03.006","article-title":"Validity and reliability of a novel Ocular Pain Assessment Survey (OPAS) in quantifying and monitoring corneal and ocular surface pain","volume":"123","author":"Qazi","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1167\/iovs.15-18133","article-title":"Corneal mechanical thresholds negatively associate with dry eye and ocular pain symptoms","volume":"57","author":"Spierer","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.08.004_bib35","first-page":"3","article-title":"L'esthesie corneenne","volume":"4","author":"Cochet","year":"1960","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib36","first-page":"513","article-title":"Measurement of corneal sensitivity to mechanical and chemical stimulation with a CO2 esthesiometer","volume":"40","author":"Belmonte","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.ophtha.2017.08.004_bib38","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1167\/iovs.04-1426","article-title":"Decreased corneal sensitivity in patients with dry eye","volume":"46","author":"Bourcier","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ophtha.2017.08.004_bib39","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ICO.0b013e318242fd60","article-title":"Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management","volume":"31","author":"Sullivan","year":"2012","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ajo.2014.02.014","article-title":"The value of tear osmolarity as a metric in evaluating the response to dry eye therapy in the clinic and in clinical trials","volume":"157","author":"Amparo","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/aos.12012","article-title":"Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications","volume":"92","author":"Sullivan","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1542-0124(12)70290-2","article-title":"Corneal pain without stain: is it real?","volume":"7","author":"Rosenthal","year":"2009","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.exer.2009.12.010","article-title":"Anatomy of the human corneal innervation","volume":"90","author":"Marfurt","year":"2010","journal-title":"Exp Eye Res"},{"issue":"5-6","key":"10.1016\/j.ophtha.2017.08.004_bib44","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/08820538.2012.711416","article-title":"In\u00a0vivo confocal microscopy in dry eye disease and related conditions","volume":"27","author":"Alhatem","year":"2012","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib45","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ophtha.2014.11.006","article-title":"Effects of corneal nerve density on the response to treatment in dry eye disease","volume":"122","author":"Kheirkhah","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2017.08.004_bib46","article-title":"In\u00a0vivo confocal microscopy demonstrates the presence of microneuromas and may allow differentiation of patients with corneal neuropathic pain from dry eye disease","volume":"58","author":"Moein","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10571-009-9430-2","article-title":"Intrathecal NGF administration reduces reactive astrocytosis and changes neurotrophin receptors expression pattern in a rat model of neuropathic pain","volume":"30","author":"Cirillo","year":"2010","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"10.1016\/j.ophtha.2017.08.004_bib48","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1523\/JNEUROSCI.5201-07.2008","article-title":"A\u00a0new nerve growth factor-mimetic peptide active on neuropathic pain in rats","volume":"28","author":"Colangelo","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.ophtha.2017.08.004_bib49","article-title":"Efficacy of autologous serum tears for treatment of severe corneal pain in patients with corneal neuropathy: an in\u00a0vivo confocal microscopy study","volume":"55","author":"Aggarwal","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2017.08.004_bib50","unstructured":"Cruzat A, Cavalcanti B, Williams C, et\u00a0al. Corneal nerve regeneration with autologous serum eye drops in treatment of severe dry eye syndrome. The Cornea Society\/Fall educational symposium; 2012; Chicago."},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib51","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bjo.2009.164780","article-title":"Corneal nerve regeneration in neurotrophic keratopathy following autologous plasma therapy","volume":"94","author":"Rao","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cbf.2870","article-title":"Platelet-derived growth factor promotes the proliferation of human umbilical cord-derived mesenchymal stem cells","volume":"31","author":"Qiu","year":"2013","journal-title":"Cell Biochem Funct"},{"issue":"Pt A","key":"10.1016\/j.ophtha.2017.08.004_bib53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/978-1-4615-0717-8_75","article-title":"Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface","volume":"506","author":"Bonini","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ICU.0b013e3283543b61","article-title":"Nerve growth factor therapy for corneal disease","volume":"23","author":"Lambiase","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2017.08.004_bib55","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bjo.85.10.1188","article-title":"Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in\u00a0vitro toxicity studies","volume":"85","author":"Poon","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2017.08.004_bib56","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","article-title":"Autologous serum application in the treatment of neurotrophic keratopathy","volume":"111","author":"Matsumoto","year":"2004","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ophtha.2017.08.004_bib57","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","article-title":"Clinical experience with a mobile ocular perfusion pump","volume":"93","author":"Ralph","year":"1975","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib59","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sj\u00f6gren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2017.08.004_bib60","first-page":"CD009327","article-title":"Autologous serum eye drops for dry eye","author":"Pan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.ophtha.2017.08.004_bib61","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ICO.0000000000000271","article-title":"Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease","volume":"33","author":"Hussain","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2017.08.004_bib62","doi-asserted-by":"crossref","first-page":"826970","DOI":"10.1155\/2014\/826970","article-title":"Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies","volume":"2014","author":"Semeraro","year":"2014","journal-title":"Biomed Res Int"},{"issue":"7","key":"10.1016\/j.ophtha.2017.08.004_bib63","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/ICO.0000000000000147","article-title":"Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sj\u00f6gren syndrome","volume":"33","author":"Hwang","year":"2014","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib64","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","article-title":"The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study","volume":"252","author":"Celebi","year":"2014","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2017.08.004_bib65","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/02713683.2013.855237","article-title":"Comparison of application systems for autologous serum eye drops","volume":"39","author":"Spaniol","year":"2014","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/02713683.2013.824987","article-title":"The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment","volume":"39","author":"Jirsova","year":"2014","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bjophthalmol-2015-306842","article-title":"Blood-derived topical therapy for ocular surface diseases","volume":"100","author":"Soni","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib68","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","article-title":"Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease","volume":"88","author":"Noble","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib69","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2017.08.004_bib70","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/02713683.2012.674609","article-title":"Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome","volume":"37","author":"Urzua","year":"2012","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.exer.2003.09.023","article-title":"Neural basis of sensation in intact and injured corneas","volume":"78","author":"Belmonte","year":"2004","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.ophtha.2017.08.004_bib72","doi-asserted-by":"crossref","first-page":"TFOS71","DOI":"10.1167\/iovs.13-13226","article-title":"The TFOS international workshop on contact lens discomfort: report of the subcommittee on neurobiology","volume":"54","author":"Stapleton","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib73","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3959(90)90024-8","article-title":"The changing role of primary afferent neurones in pain","volume":"43","author":"McMahon","year":"1990","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.ophtha.2017.08.004_bib74","first-page":"3329","article-title":"Reduction of capsaicin-induced ocular pain and neurogenic inflammation by calcium antagonists","volume":"34","author":"Gonzalez","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","article-title":"Corneal nerves in health and disease","volume":"59","author":"Shaheen","year":"2014","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib76","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.23725","article-title":"Neuropathy-associated Nav1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons","volume":"73","author":"Persson","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2017.08.004_bib77","unstructured":"Kheirkhah A, Cruzat A, Aggarwal S, et\u00a0al. Outcome of autologous serum tears with concurrent anti-inflammatory treatment in ocular surface disease. American Academy of Ophthalmology Annual Meeting 2013; PO\u00a0314."},{"issue":"6 Suppl","key":"10.1016\/j.ophtha.2017.08.004_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0004-27492008000700017","article-title":"Rationale for anti-inflammatory therapy in dry eye syndrome","volume":"71","author":"de Paiva","year":"2008","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.ophtha.2017.08.004_bib79","first-page":"299","article-title":"Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop","volume":"7","author":"Coffey","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0886-3350(01)01185-3","article-title":"Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study","volume":"28","author":"Holzer","year":"2002","journal-title":"J\u00a0Cataract Refract Surg"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib81","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1167\/iovs.11-8775","article-title":"Corneal neurotoxicity due to topical benzalkonium chloride","volume":"53","author":"Sarkar","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib82","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1167\/iovs.11-8445","article-title":"Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves","volume":"53","author":"Namavari","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib83","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2011.05.042","article-title":"Effect of leukemia inhibitory factor on corneal nerve regeneration of rabbit eyes after laser in situ keratomileusis","volume":"499","author":"Pan","year":"2011","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib84","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.sjopt.2014.06.006","article-title":"Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives","volume":"28","author":"Tu","year":"2014","journal-title":"Saudi J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib85","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","article-title":"A\u00a0randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance","volume":"138","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2017.08.004_bib86","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/ICO.0b013e3181a16472","article-title":"High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen","volume":"28","author":"Dastjerdi","year":"2009","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ophtha.2017.08.004_bib87","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/ICO.0b013e31823f8c9b","article-title":"Clinical treatment of dry eye using 0.03% tacrolimus eye drops","volume":"31","author":"Moscovici","year":"2012","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ophtha.2017.08.004_bib88","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","article-title":"Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial","volume":"131","author":"Amparo","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.08.004_bib89","first-page":"5608","article-title":"A\u00a0multi-center, double-masked, randomized, vehicle-controlled, parallel group study to evaluate the safety and efficacy of testosterone ophthalmic solution in patients with Meibomian gland dysfunction","volume":"47","author":"Schiffman","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib90","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0976-500X.195920","article-title":"Lifitegrast: a novel drug for treatment of dry eye disease","volume":"7","author":"Abidi","year":"2016","journal-title":"J\u00a0Pharmacol Pharmacother"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","article-title":"Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms","volume":"12","author":"Golub","year":"1998","journal-title":"Adv Dent Res"},{"issue":"7","key":"10.1016\/j.ophtha.2017.08.004_bib92","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/ICO.0b013e3181cda38f","article-title":"Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations","volume":"29","author":"Foulks","year":"2010","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.ophtha.2017.08.004_bib93","first-page":"CD006775","article-title":"Punctal occlusion for dry eye syndrome","author":"Ervin","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ophtha.2017.08.004_bib94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000131090","article-title":"Plugs for occlusion of the lacrimal drainage system","volume":"41","author":"Tost","year":"2008","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.ophtha.2017.08.004_bib95","first-page":"1797","article-title":"Emerging treatment options for meibomian gland dysfunction","volume":"7","author":"Qiao","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/pho.2014.3819","article-title":"Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study","volume":"33","author":"Toyos","year":"2015","journal-title":"Photomed Laser Surg"},{"issue":"11","key":"10.1016\/j.ophtha.2017.08.004_bib97","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s40265-015-0432-8","article-title":"Current and emerging therapeutic strategies for the treatment of meibomian gland dysfunction (MGD)","volume":"75","author":"Thode","year":"2015","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib98","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtos.2015.07.003","article-title":"Accelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membrane","volume":"14","author":"Cheng","year":"2016","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib99","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00006534-200001000-00024","article-title":"Nerve dependency in scarless fetal wound healing","volume":"105","author":"Stelnicki","year":"2000","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1254\/jjp.85.20","article-title":"Non-neuronal neurotransmitters and neurotrophic factors in amniotic epithelial cells: expression and function in humans and monkey","volume":"85","author":"Sakuragawa","year":"2001","journal-title":"Jpn J Pharmacol"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1097-4547(19980701)53:1<107::AID-JNR11>3.0.CO;2-6","article-title":"Synthesis and release of catecholamines by cultured monkey amniotic epithelial cells","volume":"53","author":"Elwan","year":"1998","journal-title":"J\u00a0Neurosci Res"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib102","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1097-4547(19990501)56:3<316::AID-JNR11>3.0.CO;2-Z","article-title":"Detection of dopamine D2 receptor mRNA and binding sites in monkey amniotic epithelial cells","volume":"56","author":"Elwan","year":"1999","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.ophtha.2017.08.004_bib103","unstructured":"Morkin M, Hamrah P. Pain control with amniotic membrane implant in patients with corneal neuralgia. 19th Annual International Ocular Surface Society Meeting; April, 30, 2016; Seattle, Washington."},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clae.2013.02.004","article-title":"Patient ocular conditions and clinical outcomes using a PROSE scleral device","volume":"36","author":"Dimit","year":"2013","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib105","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0161-6420(90)32589-7","article-title":"Therapeutic contact lenses","volume":"97","author":"Smiddy","year":"1990","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib106","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.icl.0000244154.76214.2d","article-title":"Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease","volume":"33","author":"Russo","year":"2007","journal-title":"Eye Contact Lens"},{"issue":"11","key":"10.1016\/j.ophtha.2017.08.004_bib107","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bbmt.2015.07.013","article-title":"Bandage soft contact lenses for ocular graft-versus-host disease","volume":"21","author":"Inamoto","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.ophtha.2017.08.004_bib108","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/ICO.0000000000000515","article-title":"Comparative evaluation of silicone hydrogel contact lenses and autologous serum for management of Sj\u00f6gren syndrome-associated dry eye","volume":"34","author":"Li","year":"2015","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9394(00)00378-0","article-title":"Gas-permeable scleral contact lens therapy in ocular surface disease","volume":"130","author":"Romero-Rangel","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2017.08.004_bib110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/ICL.0b013e318188e205","article-title":"Jupiter scleral lenses in the management of chronic graft versus host disease","volume":"34","author":"Schornack","year":"2008","journal-title":"Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib111","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajo.2009.07.037","article-title":"Clinical benefits of the Boston ocular surface prosthesis","volume":"149","author":"Stason","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib112","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ICO.0000000000000381","article-title":"Corneal nerve structure and function after long-term wear of fluid-filled scleral lens","volume":"34","author":"Wang","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib113","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.ophtha.2017.08.004_bib114","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/WCO.0b013e3283311e13","article-title":"Pharmacology and treatment of neuropathic pains","volume":"22","author":"Jensen","year":"2009","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.ophtha.2017.08.004_bib116","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00127893-200211000-00002","article-title":"Current management of postherpetic neuralgia","volume":"8","author":"Panlilio","year":"2002","journal-title":"Neurologist"},{"issue":"11","key":"10.1016\/j.ophtha.2017.08.004_bib117","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2165\/00023210-200317110-00001","article-title":"Pharmacological management of postherpetic neuralgia","volume":"17","author":"Pappagallo","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ophtha.2017.08.004_bib118","first-page":"CD011209","article-title":"Nortriptyline for neuropathic pain in adults","volume":"1","author":"Derry","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.ophtha.2017.08.004_bib120","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/j.pain.0000000000000149","article-title":"Combination of morphine with nortriptyline for neuropathic pain","volume":"156","author":"Gilron","year":"2015","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib121","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","article-title":"Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial","volume":"51","author":"Watson","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1090-3801(02)00060-5","article-title":"Factors influencing the features of postherpetic neuralgia and outcome when treated with tricyclics","volume":"7","author":"Bowsher","year":"2003","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ophtha.2017.08.004_bib123","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2016.00276","article-title":"Current status of the new antiepileptic drugs in chronic pain","volume":"7","author":"Sidhu","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ophtha.2017.08.004_bib124","first-page":"339","article-title":"Efficacy and tolerability of carbamazepine for the treatment of painful diabetic neuropathy in adults: a 12-week, open-label, multicenter study","volume":"7","author":"Saeed","year":"2014","journal-title":"Int J Gen Med"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02688690701219175","article-title":"Evidence-based approach to the medical management of trigeminal neuralgia","volume":"21","author":"Jorns","year":"2007","journal-title":"Br J Neurosurg"},{"issue":"4S","key":"10.1016\/j.ophtha.2017.08.004_bib126","first-page":"S79","article-title":"(418) A novel glial cell inhibitor, low dose naltrexone, reduces pain and depression, and improves function in chronic pain: a CHOIR study","volume":"17","author":"Noon","year":"2016","journal-title":"J\u00a0Pain"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib127","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","article-title":"The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain","volume":"33","author":"Younger","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib128","first-page":"790","article-title":"Off-label, low-dose naltrexone for refractory painful diabetic neuropathy","volume":"17","author":"Hota","year":"2016","journal-title":"Pain Med"},{"issue":"3 Suppl","key":"10.1016\/j.ophtha.2017.08.004_bib129","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.ophtha.2017.08.004_bib130","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/S0149-2918(03)80335-1","article-title":"Change in opioid use after the initiation of gabapentin therapy in patients with postherpetic neuralgia","volume":"25","author":"Berger","year":"2003","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.ophtha.2017.08.004_bib131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1086\/368196","article-title":"Treatment and prevention of postherpetic neuralgia","volume":"36","author":"Dworkin","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib132","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1527-3458.2004.tb00012.x","article-title":"The biology and pharmacology of calcium channel alpha2-delta proteins Pfizer satellite symposium to the 2003 Society for Neuroscience meeting. Sheraton New Orleans Hotel, New Orleans, LA November 10, 2003","volume":"10","author":"Taylor","year":"2004","journal-title":"CNS Drug Rev"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib133","doi-asserted-by":"crossref","first-page":"255","DOI":"10.11607\/ofph.1629","article-title":"Systematic review and meta-analysis of the efficacy of oral medications compared with placebo treatment in the management of postherpetic neuralgia","volume":"30","author":"Salah","year":"2016","journal-title":"J\u00a0Oral Facial Pain Headache"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib134","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/01.WNL.0000168259.94991.8a","article-title":"A\u00a0single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster","volume":"65","author":"Berry","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-200565010-00011","article-title":"Pregabalin: in the treatment of postherpetic neuralgia","volume":"65","author":"Frampton","year":"2005","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib136","first-page":"96","article-title":"[Pregabalin. A new treatment for neuropathic pain]","volume":"21","author":"Lopez-Trigo","year":"2006","journal-title":"Neurologia"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib137","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40261-016-0464-1","article-title":"Efficacy and safety of pregabalin for the treatment of neuropathic pain in patients undergoing hemodialysis","volume":"37","author":"Otsuki","year":"2017","journal-title":"Clin Drug Investig"},{"issue":"8","key":"10.1016\/j.ophtha.2017.08.004_bib138","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ophtha.2017.08.004_bib139","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib141","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12565-016-0360-z","article-title":"Exercise-induced hypoalgesia: potential mechanisms in animal models of neuropathic pain","volume":"92","author":"Kami","year":"2017","journal-title":"Anat Sci Int"},{"issue":"9","key":"10.1016\/j.ophtha.2017.08.004_bib142","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1097\/j.pain.0000000000000607","article-title":"Prior voluntary wheel running attenuates neuropathic pain","volume":"157","author":"Grace","year":"2016","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib143","first-page":"229","article-title":"The rationale for exercise in the management of pain in Parkinson's disease","volume":"5","author":"Allen","year":"2015","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib144","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.j.pain.0000460339.23976.12","article-title":"Exercise therapy normalizes BDNF upregulation and glial hyperactivity in a mouse model of neuropathic pain","volume":"156","author":"Almeida","year":"2015","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.ophtha.2017.08.004_bib145","doi-asserted-by":"crossref","first-page":"21167","DOI":"10.3390\/ijms141021167","article-title":"Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis","volume":"14","author":"Raphael","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ophtha.2017.08.004_bib146","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.12659\/MSM.891364","article-title":"Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies","volume":"20","author":"Liu","year":"2014","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib147","first-page":"287","article-title":"[Neurological disorders associated with gluten sensitivity]","volume":"53","author":"Hernandez-Lahoz","year":"2011","journal-title":"Rev Neurol"},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib148","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/jnnp.72.5.560","article-title":"Gluten sensitivity as a neurological illness","volume":"72","author":"Hadjivassiliou","year":"2002","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib149","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7326\/0003-4819-136-5-200203050-00010","article-title":"Acupuncture: theory, efficacy, and practice","volume":"136","author":"Kaptchuk","year":"2002","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ophtha.2017.08.004_bib150","first-page":"90","article-title":"Deep transcranial magnetic stimulation: a promising drug-free treatment modality in the treatment of chronic low back pain","volume":"88","author":"Yates","year":"2016","journal-title":"Del Med J"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib151","first-page":"CD008208","article-title":"Non-invasive brain stimulation techniques for chronic pain","author":"O'Connell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ophtha.2017.08.004_bib152","first-page":"1","article-title":"Efficacy of deep rTMS for neuropathic pain in the lower limb: a randomized, double-blind crossover trial of an h-coil and figure-8 coil","author":"Shimizu","year":"2017","journal-title":"J\u00a0Neurosurg"},{"issue":"12","key":"10.1016\/j.ophtha.2017.08.004_bib153","first-page":"1205","article-title":"rTMS for suppressing neuropathic pain: a meta-analysis","volume":"10","author":"Leung","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.ophtha.2017.08.004_bib154","first-page":"149","article-title":"Chronic pain treatment and scrambler therapy: a multicenter retrospective analysis","volume":"86","author":"Compagnone","year":"2015","journal-title":"Acta Biomed"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpainsymman.2011.03.015","article-title":"Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial","volume":"43","author":"Marineo","year":"2012","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"1","key":"10.1016\/j.ophtha.2017.08.004_bib156","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ner.12564","article-title":"The Neurostimulation Appropriateness Consensus Committee (NACC) safety guidelines for the reduction of severe neurological injury","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"issue":"5","key":"10.1016\/j.ophtha.2017.08.004_bib157","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3810\/pgm.2011.09.2469","article-title":"Review of current guidelines on the care of postherpetic neuralgia","volume":"123","author":"Argoff","year":"2011","journal-title":"Postgrad Med"},{"issue":"4","key":"10.1016\/j.ophtha.2017.08.004_bib158","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/ICO.0000000000000751","article-title":"Electrical stimulation of the trigeminal ganglion and intrathecal drug delivery systems for the management of corneal neuropathic pain","volume":"35","author":"Sayegh","year":"2016","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ophtha.2017.08.004_bib159","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/pm\/pnv058","article-title":"Successful management of corneal neuropathic pain with intrathecal targeted drug delivery","volume":"17","author":"Hayek","year":"2016","journal-title":"Pain Med"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017306127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642017306127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T21:33:35Z","timestamp":1719524015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642017306127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":159,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0161642017306127"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.004","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathic Corneal Pain","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}